{
  "id": 16674943,
  "title": "The Bundibugyo Ebola Virus Arrives in Nigeria: Its Highlights",
  "url": "https://urgent.news/2026/10/26/the-bundibugyo-ebola-virus-arrives-in-nigeria-its-highlights",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-26T23:08:00.000Z",
  "source": {
    "name": "This Day",
    "slug": "this-day",
    "url": "https://www.thisdaylive.com/2026/10/27/the-bundibugyo-ebola-virus-arrives-in-nigeria-its-highlights/"
  },
  "original_language": "en",
  "account": "The Bundibugyo Ebola Virus (BEV) has recently arrived in Nigeria, though containment efforts are ongoing. This development comes after the Democratic Republic of Congo (DRC) declared its 17th outbreak of the Ebola Virus since 1976 on May 15, 2026. According to Dr. Ismail Abdus-Salam, the Director of Epidemiology, Biosecurity, and Global Health at the Lagos State Ministry of Health, Ebola is not a single virus but a family of viruses. The Zaire strain, which reached Nigeria in 2014, is historically the deadliest, with case-fatality rates ranging from 40% to 90%. In contrast, the Bundibugyo strain, first identified in Uganda in 2007, has been less lethal, with early figures suggesting a fatality rate between 25% and 50%.\n\nDr. Abdus-Salam emphasized that Ebola is not airborne and cannot spread like flu or Covid-19. Transmission requires direct contact with the blood or body fluids of an infected individual, either through broken skin or mucous membranes, or by touching contaminated surfaces. A person infected but not yet showing symptoms is not contagious; only once sick do they become infectious. The body of someone who has died from Ebola is highly infectious, making caregivers and health workers the most at-risk individuals.\n\nIn terms of treatment, there are currently no licensed vaccines or specific medicines for the Bundibugyo strain. The Ervebo vaccine is only approved for the Zaire strain, and due to a 30% difference in their key surface proteins, it is not expected to protect reliably against the Bundibugyo strain. The Lagos Mainland Hospital in Yaba, serving as Nigeria's Ebola index case management center during the 2014 outbreak and expanded during the Covid-19 pandemic, is on high alert. Equipped with an Infectious Disease Hospital, a triage and isolation ward, intensive care unit, specialists, and an on-site Biosafety Level-3 laboratory and Biobank, the hospital is prepared to handle the virus. Dr. Abdus-Salam stressed that prevention and early care are crucial for survival, as even without a specific drug, early supportive care, including fluids, oxygen, treating co-infections, and good nursing, can save lives.",
  "summary": "The Bundibugyo Ebola Virus (BEV) has arrived in Nigeria; but, hopefully, it will be contained. On June 9, 2026, This Day Lawyer’s Cover was on the BEV. We interviewed",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}